|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02157 LEPU BIO-B
Nominal 
7.950 -0.240 (-2.930%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 465,942 | 249.588% | 367,794 | 225,352 | 15,572 | 0 |
| Cost of Sales | (27,403) | 30.230% | (74,824) | (28,277) | (2,005) | -- |
| Gross Profit | 438,539 | 290.712% | 292,970 | 197,075 | 13,567 | -- |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (16,957) | 13575.000% | 5,077 | 174,976 | (62,816) | (76,285) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (6,234) | -11.411% | (16,439) | (27,341) | (32,231) | (17,695) | |
| Profit / (Loss) before Taxation | 29,302 | -- | (424,193) | (30,301) | (699,441) | (1,028,869) | |
| Taxation | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 12,443 | 174.317% | 12,817 | 8,205 | 10,389 | 17,873 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 41,745 | -- | (411,376) | (22,096) | (689,052) | (1,010,996) | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 7,445 | 26.336% | 16,989 | 7,756 | (37,272) | 1,538 |
| Depreciation & Amortisation | 47,186 | 0.108% | 100,179 | 102,572 | 95,446 | 95,246 |
| Directors' Emoluments | -- | -- | 3,930 | 15,291 | 18,828 | 25,525 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 2.000 | -- | -24.000 | -1.000 | -42.000 | -66.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.116) | (0.151) | (0.293) | (0.409) |
| NBV per share ($) | 0.436 | -- | 0.411 | 0.540 | 0.543 | -- |
| Remarks: | Real time quote last updated: 11/09/2025 17:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 41,745 |
| %Change | -- |
| EPS / (LPS) | RMB 0.020 |
| NBV Per Share (¥) | RMB 0.436 |